Category Archives: XBI

Uber … in the Channel

January 5, 2026 By in $SPSIBI, Biotech, SPBIO, UBER, UBER-26-01, XBI 2 Comments

False Breakout?

The chart of Uber is similar to biotech XBI, from last year, link here.

Back then, it looked like there was a breakout from a trading channel.

That update said:

“If the trendline is in-effect, meaning the market’s hanging in mid-air in a false breakout, getting back into that trend may result in some dramatic downside action.”

That’s what happened. Biotech collapsed in to the ‘Tariff’ meltdown.

Is that where we are now, with UBER? (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … The Set-Up

December 23, 2025 By in Biotech, LABD, Wyckoff, David Weis, SPBIO, Spring-to-Up-Thrust, $SPSIBI, XBI, LABD-25-22

Repeating Pattern

The last update on biotech, XBI was here.

Price action went on to post a new high and, in the process, may have completed a repeating pattern set-up:

Spring-to-Up-Thrust, link here.

The indication is subtle.

There’s no doubt we’re at the very edge of the lake as Wyckoff (and Weis) used to call it.

However, this is also the point where the risk (for a short) is least (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Anatomy of a Reversal

December 11, 2025 By in $SPSIBI, Biotech, LABD, LABD-25-20, SPBIO, Up-Thrust, Wyckoff, XBI 1 Comment

Wyckoff Schematic

An excellent schematic tutorial on Wyckoff, can be found here.

Going to the link, scrolling down to ‘Distribution’, we have a schematic that includes the notation “UTAD”.

UTAD, stands for, Upthrust After Distribution.

The accompanying text for the schematic indicates the distribution has already taken place; UTAD, is essentially a ‘last gasp’ to see if there’s any more demand.

A fascinating question would be, ‘Was the heavy volume associated with this update an indication of distribution?’

Does that mean the subsequent blip higher in this update, was essentially UTAD?

Biotech XBI, Hourly

The heavy volume (potential) distribution is noted.

If this is a correct view of XBI, then right now, it’s at The Danger Point®; where risk on a short is least (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech, Hangs at The Wedge

December 10, 2025 By in Biotech, LABD, Wyckoff, SPBIO, $SPSIBI, Federal Reserve, XBI, Up-Thrust, LABD-25-20 1 Comment

Waiting for The Fed?

The last update on biotech presented what was thought to be a reversal condition.

The huge downward thrust with volume, was taken as the clue, some large entity or entities (may) have just exited the market.

Well, it’s been seven trading days since then and it looks like we might be at a pivot point (not advice, not a recommendation).

Biotech XBI, Daily

The reversal (Wyckoff up-thrust) was nearly textbook. The only thing absent, was a lower close for that day.

We’re now hovering at the edge.

The Fed announcement is just over an hour away.

Anything can happen.

MACD (magenta arrow) shows momentum has slowed and lines have crossed to the downside.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (reversal) Bookends

December 3, 2025 By in $SPSIBI, Biotech, LABD, LABD-25-19, SPBIO, XBI 2 Comments

Repeating Characteristics

Yesterday, biotech XBI was down on the most volume since May 6th, of this year.

For leveraged inverse fund LABD, it posted the heaviest upside volume, ever.

The chart shows a (potential) repeating characteristic for XBI that occurs at the point of trend change (not advice, not a recommendation).

As always, anything can happen and today’s ‘test’ could fail with XBI continuing higher.

Biotech XBI, Daily Close

The ‘up-thrust’ reversal zone is between support/resistance areas (far left, off chart) at the approximate location of the 50% retrace.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Stalls @ 50%

December 2, 2025 By in Biotech, LABD, SPBIO, XBI, LABD-25-19 1 Comment

While All Eyes Focused, on A.I.

At left, the entire biotech (XBI) move from all-time highs to the lows and now, stalled at 50% retrace.

Last week was Fibonacci Week 34, from the ‘Tariff’ lows of early April.

The insert at left is a closer look.

Note how the index has essentially gone straight-up without any testing or (significant) price action congestion.

This behavior suggests a down move may happen just as easily (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Reversal to Wedge

November 18, 2025 By in $SPSIBI, Biotech, LABD, LABD-25-17, Up-Thrust, XBI

The Bulls, Back Off

As the chart shows, we have a terminating wedge.

The prior update (here) proposed we’re in up-thrust (reversal) condition.

That set-up subsequently morphed into the wedge, shown.

Either way, we’re not far away.

Price action closed today, down 0.18-pts below the high of the last update, November 14th.

During the past two trading sessions, volume has been consecutively lower; suggesting the bulls are backing off (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech At The Edge

November 15, 2025 By in $SPSIBI, Biotech, LABD, LABD-25-16, SPBIO, Up-Thrust, XBI 1 Comment

Bearish MACD

The chart shows biotech XBI, struggling at resistance (blue line).

At the same time, we have a bearish divergence on MACD.

Taking a look at the components of XBI, link here, seven of those in the top ten, have no P/E at all (not advice, not a recommendation).

What could go wrong?

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

‘Big Short’ Burry, Closes Fund

November 14, 2025 By in Artificial Intelligence, Biotech, CVNA, LABD, LABD-25-16, NVDA, QTR Fringe Finance, Semiconductors, SOXX, SPBIO, Spring-to-Up-Thrust, Up-Thrust, Wyckoff, XBI

Signs of A (The) Top

Warren Buffett has a massive cash hoard; now, famous short-seller Michael Burry is calling it quits, links here, here and here.

The last time this type of news happened in a big way, was right around the Nasdaq peak in 2000 (not advice not a recommendation).

Back then, ‘old-timers’ with forty-years in the business, were throwing up their hands, throwing in the towel and retiring; the market ‘did not make sense anymore’.

NVDA, CVNA & Biotech

With Nvidia posting a new low today, the analysis shown here, is proving to be accurate thus far (not advice, not a recommendation)

Additionally, Carvana posted an up-thrust (reversal) as presented in this post (not advice, not a recommendation).

Next up, is biotech, XBI.

Biotech XBI, Hourly

We’re in up-thrust condition (potential reversal) have a ‘sign of supply’ and now testing the upside.

Note: The ‘test’ has exceeded the previous high. Although rare, it can happen.

So, is it a test or a continuation of an upside breakout?

The rest of the markets seem to be in a similar condition.

Carvana just posted a new daily high (as of 11:25 a.m., EST), possibly taking out the (early) shorts.

Let’s see if it manages to close above that 332.33, level discussed in this post (not advice, to a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Miners, pre-market, Target

November 10, 2025 By in ABD-25-15, Banking, Biotech, GDX, GDXJ, Gold & Silver, Gold Miners, LABD, LABD-25-15, Up-Thrust, XBI, XLF

Inflation Higher, Deflation Lower

As of 7:55 a.m., EST, Senior Miners GDX are trading in the area of the dashed magenta line.

The prior two updates (here and here) targeted this area as a potential location for retrace and reversal (not advice, not a recommendation).

Toggling between the two charts, shows price action is actually in the middle of the (prior) target areas.

Other Markets the Same

Several other markets are in the same (retrace, up-thrust) position; specifically, XLF and XBI.

We’ll cover those in another update, if price action warrants.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279